Securities Class Action Lawsuit Filed Against Tenax Therapeutics, Inc.
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
A class action securities lawsuit was filed against Tenax Therapeutics, Inc. on October 29, 2026. The suit represents investors who purchased Tenax Therapeutics, Inc. securities and alleges securities fraud occurred between November 13, 2023, and August 7, 2026. The complaint claims the company made false statements regarding the effectiveness and prospects of its lead clinical program, TNX-103.
From pr-inside.com
Why it matters
The lawsuit alleges that Tenax Therapeutics, Inc. overstated the clinical, regulatory, and commercial prospects of TNX-103. These claims could impact investor confidence and the company's market valuation.
From pr-inside.com
Who's involved
Keep exploring
The entities involved
-
TenX
A human centered design and technology studio.
Nothing else this week.
-
Nasdaq
American fully electronic stock exchange
Related events
- Marex Group disclosed a sale transaction in a legal filing with the SEC while its shares are traded on Nasdaq.
- Concentrix securities were traded on the Nasdaq exchange on October 21, 2026.
- A lawsuit was filed in the Western District of Washington against Coastal Financial Corporation, whose stock trades on Nasdaq.
- Yunhong Green CTI stock was traded on the Nasdaq exchange and filed required disclosures with the Securities and Exchange Commission on August 7, 2026.
- Viasat files disclosures with the SEC and its stock trades on the Nasdaq exchange on August 5, 2026.